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Renal hemodynamics and segmental tubular reabsorption in early type
1 diabetes. To investigate mechanisms underlying GFR control in
diabetes mellitus, renal hemodynamics and segmental tubular handling
of sodium, using lithium clearance, were assessed in 41 insulin-depen-
dent diabetics (IDD) treated by insulin for II 8 days, and in 19 normal
controls. Average GFR and effective renal plasma flow (ERPF) were
slightly but not significantly higher (136 22 vs. 123 16 ml/min 1.73
m2) in IDD than in normal subjects. GFR and ERPF were positively and
strongly correlated in controls (r = 0.61, P < 0.001) and in diabetics (r
= 0.72, P < 0.0001) indicating the marked flow dependency of GFR in
both populations. After adjustment for ERPF, GFR was significantly
higher in diabetics, suggesting a role of increased glomerular capillary
pressure and ultrafiltration coefficient in the subset of "hyperfiltering"
patients. Both fractional (FPRNa) and absolute (APRNa) proximal
sodium reabsorption were significantly higher in IDD and significantly
correlated with GFR. The ensuing decrease in sodium distal delivery
could deactivate the tubuloglomerular feedback response and thus
favor sustained vasodilation and high GFR in some diabetics. The renal
effects of acute administration of drugs acting predominantly at either
the pre- or the postglomerular resistance using nicardipine (N = 16) or
captopril (N = 25) were further evaluated in IDD. The renal response to
captopril or nicardipine was different in IDD. Whereas both drugs
induced a marked decrease in renal vascular resistance, GFR was
slightly decreased by captopril and was unchanged after nicardipine;
these results are similar to those observed in normotensive non-diabetic
subjects. Despite a mild decrease after captopril, FPRNa did not return
to normal control values and no natriuretic effect was demonstrated in
IDD, in contrast to normotensive subjects. In IDD nicardipine induced
marked natriuresis by decreasing both the proximal and distal reabsorp-
tion rate of sodium, possibly due to a direct tubular effect, a response
which was similar to that of non-diabetics. These results suggest that
the increased FRPN observed in diabetics is not related to angiotensin
formation or hemodynamic changes but rather may represent an
independent mechanism possibly supported through sodium-glucose
cotransport.
The early stages of diabetes mellitus are characterized by
renal hemodynamic changes leading to a wide range of glomer-
ular filtration rates (GFR) from normal to high values in humans
[1—3] and in animals [4, 5]. Attention has been focused on the
mechanisms of glomerular hyperfiltration, since high single
nephron glomerular filtration and plasma flow due to preglomer-
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ular vasodilation and increased glomerular capillary pressure
have been found in moderately hyperglycemic rats [4], and
recent evidence has suggested that these abnormalities may be
involved in the initiation and progression of diabetic nephrop-
athy 16, 7].
The underlying mechanisms of glomerular hyperfiltration and
of renal hemodynamic changes in diabetes mellitus are not yet
clearly defined. Some previous studies in insulin-dependent
diabetics (IDD) have suggested that elevated glomerular filtra-
tion rate (GFR) may be associated with increased renal plasma
flow (RPF) [2, 8, 9] and possibly a decrease in renal vascular
resistance (RVR) [101. However, other reports demonstrated
either normal [11] or reduced [12] RPF in hyperfiltering IDDM
patients. Such discrepancies may be related to heterogeneity in
the duration of diabetes or insulin treatment.
Renal sodium reabsorption has been found to be increased in
diabetic patients [10, 13] and, using lithium clearance as a
marker of sodium distal delivery, BrØchner-Mortensen et al[l4]
reported that FPRNa was elevated and glomerulo-tubular bal-
ance was preserved in hyperfiltering diabetic patients, whereas
absolute distal delivery of sodium was similar in IDDM and
normal subjects.
The aim of the present study was to examine both renal
hemodynamics and segmental tubular sodium reabsorption,
evaluated by lithium clearance, in an homogeneous group of
very recent onset diabetes mellitus patients under relatively
good metabolic control, and to determine the influence upon
these parameters of acute administration of drugs acting pre-
dominantly either at the pre- or the postglomerular resistance,
namely the calcium channel blocker (CCB), nicardipine, or the
angiotensin converting enzyme inhibitor (ACE!), captopril.
Methods
Forty-one insulin-dependent diabetics (16 females, 25 males)
were investigated after informed consent. All had very recent
onset type 1 diabetes mellitus with a mean duration of 118 77
days and had received insulin treatment for less than four weeks
(11 8 days). Subjects were included in the study after
correction of hyperglycemia by conventional insulin therapy;
blood glucose levels were below 9 mmol/liter (6 2 mmoL/liter;
mean SD), as estimated by the mean of six consecutive
determinations during each clearance procedure. Since PAH
clearance may be underestimated by glucose-PAH adduct for-
mation or lithium clearance overestimated due to osmotic
1126
Hannedouche et a!: Hemodynainics and Na handling in IDD 1127
Table 1. General data in IDDM patien ts (N = 41)
Age
years
Diabetes
duration
Insulin
therapy Plasmaglucose
mmol/liter
HbA1c
%
PProt PAIb
days giliter
27±8 118±77 11±8 6±2 12±3 65±6 38±3
Values are expressed as mean SD. Plasma glucose of each patient is the mean of six consecutive measurements obtained every 30 mm during
the clearance study. Abbreviations are: PProt, plasma protein concentration; PAIb, plasma albumin concentration; HBA1c, glycolysated
hemoglobin.
diuresis, patients were definitively included after absence of
ketone and glucose had been carefully checked in each urine
sample for all patients (glucose oxydase dipsticks, sensibility
<0.1 mmol/liter). None of the subjects was taking drugs other
than insulin and all received a normal sodium diet. Other
pertinent general data are given in Table 1. Nineteen healthy
subjects (8 females, 11 males; aged 23 to 28 years) also
participated in the study as controls. Renal or cardiovascular
disease had been excluded in controls by appropriate clinical
and laboratory investigations. They were also placed on a
normal sodium diet for one week prior to the study day.
The evening before the clearance studies, each participant
was given 750 mg lithium carbonate orally in order to obtain
throughout the clearance procedure relatively stable lithium
concentrations ranging from 0.20 to 0.25 mmol/liter. All sub-
jects were studied in the morning after an overnight fast and
diabetic patients received no insulin until after the end of the
clearance procedure. On arrival at the laboratory on the day of
investigation, each subject drank 600 ml of tap water 20 minutes
before bladder emptying. Water loading was sustained by an
intake of 300 ml of tap water orally every 30 minutes during the
study. Measurements were performed in the supine position
(except when standing to void). A priming dose of inulin
(polyfructosan, mutest® Laevosan, Linz, Austria) and para-
aminohippuric acid (PAH, Nephrotest®, Biologische Arbeitsge-
meinschaft GmbH, Lich, FRG) was followed by a sustaining
dose of a solution of inulin and PAH in normal saline (0.9 g/dl)
administered by infusion pump at a constant rate to obtain
plasma concentrations of inulin and PAH of 20 and 2.0 mg/dl,
respectively. After a 60-minute equilibration period, six consec-
utive clearance periods of 30 minutes each in diabetic patients
and three consecutive clearance periods of 30 minutes each in
controls were evaluated. Urine was collected every 30 minutes
by spontaneous voiding and blood specimens were drawn at the
beginning and the end of each collection period. Immediately
after the end of period 3, sublingual administration of 75 mg of
captopril or i.v. administration of 2.5 mg of nicardipine was
given as a single dose in diabetics. Serum angiotensin convert-
ing enzyme activity was measured [15] before and 60 minutes
after captopril administration.
The following parameters were measured: mean arterial
pressures (MAP) every 10 minutes with an automatic device
(Dinamap, Critikon, Florida, USA; cuff size 23 X 13 cm),
plasma and urine electrolytes by IL 243 flame photometry
(Instrumentation Laboratory, Milano, Italy), plasma and urine
lithium by atomic absorption spectrophotometry (PU 9000,
PYE Unicam Ltd, Cambridge, UK), hematocrit by routine
Coulter counter (Coulter Electronics, Hileah, Florida, USA)
and plasma and urine concentrations of PAH and inulin by
Technicon autoanalyzer I (Technicon Instrument Corp., Tarry-
town, New York, USA) [16, 17].
Clearance of various substances was calculated according to
the standard clearance formula C = U V — P, where V is urine
flow, U urine concentration of the substance and P its plasma
concentration. The clearance of para-aminohippuric acid was
taken as a measurement of effective renal plasma flow (ERPF),
and the clearance of inulin as a measurement of glomerular
filtration rate (GFR). Filtered fraction (FF) was calculated as
GFR ÷ ERPF and renal vascular resistance (RVR) as MAP x
(1 — Ht) ERPF x 80000, where MAP is mean arterial
pressure and Hct is hematocrit. Segmental tubular sodium
handling was estimated using the lithium clearance (CL1) [18,
19]. Fractional proximal sodium reabsorption (FPRNa) was
calculated as 1 — CLI ÷ GFR and fractional distal sodium
reabsorption (FDRNa) as 1 — CNa ÷ CLI. Other values were
calculated as follows: absolute proximal sodium reabsorption
rate (APRNa) = (GFR — CLI) X 'DNa X i03, where 'DNa is the
plasma sodium concentration; absolute distal fluid delivery
(ADD) = CLI; fractional distal delivery (FDD) = CLI GFR;
absolute distal sodium reabsorption (ADRNa) = (CLI — CNa) x
'>Na X l0, filtered load of sodium (FLNa) =GFR X Na
and fractional excretion of sodium (FENa) = CNa ÷ GFR.
Statistics
Calculations for each diabetic patient were obtained from the
means of measurements in all three periods before and after
administration of either captopril or nicardipine. Calculations
for each of the controls were likewise obtained from the means
of all three periods. Data were adjusted for a body surface of
1.73 m2 and are expressed as mean standard deviation. The
paired Student's t-test was used for intragroup analysis and the
unpaired Student's t-test for intergroup analysis. Differences
between means were considered significant at the 0.05 level.
Simple linear regression was used for comparison between GFR
and ERPF and between GFR and FDD in diabetics and con-
trols. Analysis of covariance was used to compare the level of
GFR after controlling for RPF and FDD and to compare the
slopes of the two regression lines in the diabetic and the control
groups (BMDP Statistical Software, Berkeley, California,
USA).
Results
Baseline renal hemodynamic and segmental tubular handling
of sodium
Results of baseline renal hemodynamic and segmental tubular
function studies in both the diabetic and the normal control
groups are summarized in Table 2. IDD patients had slightly
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Table 2. Baseline renal hemodynamics and segmental tubular
handling of sodium in diabetic patients and in normal controls
Controls
(N= 19)
Diabetics
(N=41)
Renal hemodynamics
GFR mI/mm 1.73 In2 128 14 136 22
ERPF mi/mm 1.73 m2 709 115 685 136
FF 0.183 0.020 0.202 O.O29
MAP mm Hg 91 9 86 10
RVR dyne sec cm5 6330 875 6365 1550
Tubular sodium handling
FENa 0.015 0.005 0.018 0.008
UNa V mmol/min 1.73 m2 0.277 0.088 0.330 0.lSlc
FLNa mmol/min 1.73 m
ADD mi/mm 1.73 in2
18.11 1.88
34.12 4.95
19.02 3.15
31.48 5.16c
FDD 0.268 0.036 0.234 0043b
FPRNa
APRNa inmol/min 1.73 in2
0.732 0.036
13.27 1.65
0.766
14.94 2.99a
FDRNa 0.942 0.018 0.924 0.033a
ADRNa inmol/min 1.73 in2 4.52 0.68 3.76 l.4la
Abbreviations are: GFR, glomerular filtration rate; ERPF, effective
renal plasma flow; FF, filtration fraction; MAP, mean arterial pressure;
RVR, renal vascular resistance; FLNa, filtered load of sodium; ADD,
absolute distal delivery of sodium; FDD, fractional distal delivery of
sodium; FPRNa, fractional proximal sodium reabsorption rate; APRNa,
absolute proximal sodium reabsorption rate; FDRNa, fractional distal
sodium reabsorption rate; ADRNa, absolute distal sodium reabsorption
rate; FENa, fractional sodium excretion; UNa V. urinary sodium
excretion.
a P < 0.05; b p < 0.01; C 0.05 <P < 0.10 diabetics vs. controls
higher mean values for GFR than normal subjects (136 22 vs.
128 14 ml/min 1.73 m2). In spite of relatively good metabolic
control at the time of this study, GFR was above 152 ml/min
1.73 m2 (controls mean 2 SD) in 8 out of 41 diabetic patients
(19.5%). The two groups demonstrated no significant difference
in mean values for ERPF and RVR although FF was signifi-
cantly higher in IDD patients (0.202 0.029 vs. 0.183 0.02, P
<0.01). Mean arterial pressure was slightly but not significantly
lower in the diabetic group as compared to controls (86 10 vs.
91.2 9.3 mm Hg). The correlation between GFR and ERPF
was highly significant in both diabetics (r = 0.72, P < 0.0001)
and controls (r = 0.61, P < 0.01; Fig. 1). After adjustment for
RPF, mean values of GFR were 137 mI/mm 1.73 m2 in
diabetics and significantly higher than adjusted values of GFR
in controls (126 ml/min 1.73 m2, P <0.01). GFR was inversely
correlated with RVR; the higher the GFR values, the lower the
values for RVR (r =
—0.63, P < 0.0001).
The filtered sodium load (FLNa) averaged 19.02 3.15 in the
diabetics and 18.11 1.88 mmol/min 1.73 m2 in the normal
subjects. The mean absolute proximal sodium reabsorption
(APRNa) and the mean fractional proximal sodium reabsorption
rates (FPRNa) were significantly higher in IDDM patients than
in controls (Table 2). Whereas the absolute distal fluid delivery
(ADD) showed a trend toward significant reduction in the
diabetic group (31.5 5.1 vs. 34.12 4.95 mI/mm 1.73 m2,
0.05 <P < 0.08), fractional distal sodium delivery (FDD) was
significantly lower in diabetic patients (0.23 0.04 vs. 0.27
0.03, P < 0.005).
Fractional distal sodium reabsorption (FDRNa) and absolute
distal sodium reabsorption rates (ADRNa) in IDD patients were
slightly but statistically lower on the average than in controls
(Table 2). Thus, while FPRNa was elevated in !DDM subjects,
a slight reduction in FDRNa may account for the trend toward
higher urinary excretion of sodium (UNa . V) in IDD, as
compared to the normal control group (0.33 0.15 vs. 0.27
0.08 mmol/min 1.73 m2, 0.05 <P < 0.10).
GFR was significantly correlated with APRNa (' = 0.97, P <
0.0001), demonstrating that variations in GFR were associated
with proportional changes in absolute proximal sodium reab-
sorption rate and that glomerulotubular balance was main-
tained. An inverse correlation was found between GFR and
FDD (r = 0.54, P < 0.001) indicating that the lower the FDD,
the higher the GFR (Fig. 2). After adjustment for FDD, GFR
was similar in diabetics and controls (134 3 vs. 132 4 mI/mm
1.73 m2, NS) and the slope of the relationship between FDD
and GFR was similar in diabetics and controls. No correlation
was found between GFR on the one hand and plasma protein
concentration, plasma albumin concentration, glycosylated he-
moglobin, filtration fraction (FF), ADRNa or FDRNa on the
other hand.
Renal hemodynamics and segmental tubular handling of
sodium before and after either captopril or nicardipine
Diabetics were acutely given either the angiotensin convert-
ing enzyme inhibitor captopril (N = 25) or the calcium antago-
nist, nicardipine, (N = 16) to analyze the respective effects of
the two drugs upon renal hemodynamics and segmental tubular
function. Results are shown in Tables 3 and 4. No significant
differences were found between the two groups in baseline
values for glycosylated hemoglobin, insulin therapy duration,
plasma glucose or GFR.
After a single dose of captopril, angiotensin converting en-
zyme activity fell from 19.8 8.4 to 1.7 1.7 p.mollmin ml (P
<0.001), indicating a near complete inhibition of angiotensin II
formation. Acute captopril and nicardipine administration re-
duced mean blood pressure to a similar degree in each group.
However, captopril significantly reduced the mean GFR values
in diabetics, whereas GFR was unchanged following nicar-
dipine. FF decreased slightly but significantly after calcium
antagonist administration but this decrease was even more
pronounced after ACE inhibition. ERPF, on the average,
increased slightly but not significantly in both groups. The renal
vascular resistance was significantly reduced after both ACE!
(6300 1730 vs. 5720 1430 dyne sec cm5) and CA
administration (6460 1260 vs. 5990 1440 dyne sec cm5)
when compared to baseline values.
While FPRNa declined from 0.77 0.04 to 0.75 0.05 (P <
0.001), FDRNa was unchanged in the ACE! group. Since FLNa
was reduced in this group and FDRNa was unchanged, FENa
and UNO V remained practically unaltered after captopril.
However, nicardipine administration induced a slight but sig-
nificant reduction in both FPRNa and FDRNa, and since FLNa
was unchanged, FENa and UNa V increased significantly from
0.018 0.007 to 0.022 0.006 (P < 0.01) and from 310 130
to 370 120 smol/min 1.73 m2 (P <0.05), respectively (Table
4). Thus, nicardipine but not captopril induced an acute natri-
uretic effect in IDDM patients.
Linear regression analysis found no significant correlation
between GFR and changes in GFR (GFR) or ERPF (ERPF)
in any group. There was a significant negative correlation
between zGFR and ERPF in the ACE! group (r = —0.78, P <
Fig. 1. Correlation between effective renal
plasma flow (ERPF) and glomerular filtration
rate (GFR) in diabetics (U) and controls (0).
The correlation was highly significant in both
diabetic patients (r = 0.72; P < 0.0001) and
controls (r = 0.61; P < 0.001). After
adjustment for ERPF, GFR was significantly
80 100 120 140 160 180 200 higher in diabetics than in controls (P < 0.01).
IDD: y = 75.989 + 4.4788x, r = 0.72.
Controls: y = 65.638 + 5.0254x, r = 0.61.
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0.0001) and a significant positive correlation in the CA group (r
= 0.75, P < 0.001). A statistically significant correlation be-
tween LGFR and changes in APRNa (APRNa) was found in
Fig. 2. Correlation between fractional distal
delivery (FDD) and glomerular filtration rate(GFR) in diabetics (•) and controls (0). The
correlation was significant in both IDDM (r =
0.55; P < 0.01) and controls (r = 0.34; P <
0.01). After adjustment for FDD, GFR and
the slope of the relationship between FDD
and GFR were similar in diabetics and
controls. IDD: y = 0,37774 — l.OSlle-3x, r
0.55. Controls: y = 0.39811 — l.0724e-3x, r =
0.34.
both the ACEI group (r = 0.97; P < 0.0001) and the CA group(r = 0.92; P < 0.0001) while such a correlation could not be
found between zIGFR and ZFPRNa or FDRNa in either group.
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Table 3. Renal hemodynamics in diabetics before and after either acute captopril or nicardipine administration
ACEI group (N = 25) CA group (N = 16)
Before After Before After
GFR mi/mm 1.73 m2 139 2 128 27" 131 17 127 17
ERPF mI/mm 1.73 m2 701 139 733 132 659 132 670 128
FF 0.201 0.028 0.177 0.029C 0.204 0.031 0.194 0.029&
MAP mm Hg 86.4 10.3 82.7 9.Oa 85.7 9.4 80.9 7.6"
RVR dyne sec cm5 6300 1700 5720 l4301 6460 1260 5990 1140C
2.
ACEI group is angiotensin converting enzyme inhibitor group and CA group is calcium antagonist group. Abbreviations are as defined in Table
a P < 0,05; b p < 0.01; C p < 0.001 before vs. after either captopril or nicardipine administration
Table 4. Segmental tubular handling of sodium in diabetics before and after either ac ute captopril or nicardipine administration
ACEI group (N = 25) CA group (N = 16)
Before After Before After
FLNa mmol/min 1.73 n2
ADD mi/mm 1.73 m2
19.38 3.72 17.99 3.76a
31.3 5.0 31.5 5.9
18.62 2.4
31.7 5.5
18.07 2.33
33.1 8.3
FDD 0.225 0.044 0.257 O,O65 0.244 0.041 0.278 0.064
FPRNa
APRNa mmol/min 1.73 m2
FDRNa
ADRNa mmol/min 1.73 m2
FENa
UNa V mmollmin 1.73 m2
0.775 0.044 0.752 0.056
16.56 3.41 13.92 3.15"
0.82 0.03 0.82 0.03
3.66 1.49 3.70 1.59
0.018 0.008 0.019 0.007
0.345 0.06 0.343 0.12
0.756 0.041
14.03 2.14
0.92 0.02
3.89 1.33
0.018 0.007
0.310 0.13
0.740 0.06l
13.37 2.14
0.91 o.02
4.00 1.60
0.022 0006b
0.370 0.12a
ACEL group is angiotensin converting enzyme inhibitor group and CA group is calcium antagonist group. Abbreviations are in Table 2.
a p < 0.05 "P < 0.01; C P < 0.001 before vs. after either captopril or nicardipine administration
Discussion
In this study, newly diagnosed IDDM patients exhibited
near-normal mean values for GFR under relatively good meta-
bolic control obtained by several days (mean = 11 days) of
insulin therapy. The GFR in diabetics differs from controls in
that it exhibits much more variability particularly in the upper
range, with 8 out of 41 diabetic patients (19.5%) still demon-
strating elevated GFR (> 152 mI/mm 1.73 m2) in these
near-normoglycemic conditions. GFR has been found to be high
in diabetics before starting insulin therapy [1, 2] and declined to
near-normal values after a few days of improved metabolic
control [2]. The increased GFR is accompanied by an increase
in kidney size and total glomerular capillary surface area in
human as well as experimental diabetes [1, 2, 4, 20], and this
has been proposed as one of the main causes of hyperfiltration
in IDDM [8, 9, 21]. However, these morphologic abnormalities
remain unchanged despite rapid reduction in GFR by insulin
therapy [2, 22], suggesting that a considerable part of the
increase in GFR is due to hemodynamic changes.
Although mean values of ERPF and RVR in our diabetic
patients were not significantly different when compared to
control values, a strong linear relationship was found between
GFR and ERPF, together with a negative correlation between
GFR and RVR. These results indicate a marked plasma flow
dependency of GFR in diabetic patients and suggest that
hyperperfusion due to renal vasodilation may account in part
for the increase in GFR seen in this condition. Although a
similar correlation between GFR and ERPF was evidenced in
controls, the GFR adjusted for ERPF was significantly higher in
diabetics than in controls indicating, as suggested by signifi-
cantly higher FF in diabetics, that other factors such as elevated
'gC or increased K may also play a substantial role.
Studies on ERPF in human diabetics are conflicting, demon-
strating elevated [2, 8, 9], normal [11], or even reduced [12]
ERPF, associated with increases in GFR, These differences
could be related to different experimental designs, duration of
diabetes or degree of metabolic control. Furthermore, insulin,
by reducing the ERPF [23], and glycosuria, by a possible urine
PAH-glucose conjugate [24], are potential sources of ERPF
underestimation. Interestingly, Wiseman et al recently demon-
strated elevated ERPF combined with reduced RVR in hyper-
filtering diabetics under euglycemic conditions [10]. Experi-
mental studies in the streptozotocin diabetic rat have indicated
that diabetes induces a marked decrease in glomerular arteriolar
resistance, in particular afferent resistance (RA), associated
with a corresponding elevation in single nephron plasma flow
rate, glomerular transcapillary hydraulic pressure gradient (P)
and single nephron GFR [4, 6].
Lithium clearance has been used to estimate segmental
tubular sodium handling in both human and animal experiments
[18, 19]. Possible limitations in its applicability may be severe
sodium restriction [25, 26] and osmotic diuresis by urea or
glucose [27], neither of these conditions being present in our
study. Lithium clearance is generally held to be a reliable
marker of distal delivery [18]. The micropuncture study by
Haylett and Kashgarian [28] indicated that about 19% of the
filtered lithium was reabsorbed between the late accessible
convoluted proximal tubule and the early distal tubule, lithium
transport being negligible beyond this site. The largest part of
this lithium is probably reabsorbed in the pars recta, but some
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authors suggested that lithium transport may also occur in man
in the more distal sites of the nephron, particularly the thick
ascending limb of Henle's loop. The most recent data, however,
indicate that the relative contribution of this distal reabsorption
seems to be minimal in the absence of sodium depletion [26, 291.
Lithium clearance could therefore be held as a reasonable index
of the flow rate of sodium delivered to the macula densa, and
CLI per ml GFR could be used as an index of fractional distal
delivery.
Fractional and absolute proximal sodium reabsorption rate
were increased in diabetics when compared to controls as
previously suggested by BrØchner-Mortensen et at [141. This
enhanced proximal sodium reabsorption may be supported by
glucose-sodium co-transport, since sodium is linked to glucose
reabsorption in the proximal tubule [30] and maximum tubular
transport capacity for glucose (TmG) is elevated in diabetics
[10, 14]. In tubular cell suspension examined using magnetic
nuclear resonance, Kumar, Gupta and Spitzer found that Na-K
ATPase activity and Na intracellular content increase in
parallel with the filtered load of glucose [31]. Despite afew days
of insulin treatment, our diabetic patients still exhibit mild
hyperglycemia (Table 1) and increased filtered load of glucose.
Although insulin per se has been found to increase tubular
sodium reabsorption, DeFronzo et at reported that this effect
may be prominent in the distal sites of the nephron [321.
Moreover, in our study all diabetic patients had been off insulin
therapy for at least 12 hours when evaluated using the clearance
procedure.
In addition, the fraction of fluid and sodium delivered from
the proximal tubule to the distal segments, that is, fractional
distal delivery, was lower in diabetics (Table 2). Since an
increase in macula densa NaCI delivery is known to elicit
preglomerular vasoconstriction mediated through the tubulo-
glomerular feedback system (TGF) [33], the reduction in distal
delivery of sodium found in near euglycemic diabetics could
conversely have deactivated the TGF response, thus allowing
persistent high GFR. Moreover, the significant negative corre-
lation between GFR and FDD (Fig. 2) observed in diabetics
over the entire range of GFR values suggested strongly that the
TGF system may intervene, at least in part, in the physiological
regulation of renal vascular tone and GFR in diabetes. The
slopes of the relationship between FDD and GFR were signif-
icant and similar in both diabetics and controls, and GFR
adjusted for FDD were similar in both groups, indicating that
the higher values of GFR in diabetics were actually related to a
decrease in the fractional distal delivery of water and sodium.
Further evidence for a role of deactivated TGF response in
diabetic patients came from experiments using the carbonic
anhydrase inhibitor acetazolamide to decrease sodium proximal
reabsorption rate and increase distal delivery [34]. A single dose
of acetazolamide (5 mg/kg body wt) infused to 15 diabetics
decreased significantly absolute proximal reabsorption from 106
22 to 73 16 mlimin 1.73 m2 (—31%, P < 0.0001) and GFR
from 137 24 to ill 17 ml/min 1.73 m2 (—20%; P <0.0001),
suggesting that diabetics adequately respond to an increase in
distal delivery by decreasing GFR. The magnitude of the
decrease was directly correlated with the baseline GFR or
inversely with the initial FDD, the higher the baseline GFR or
the lower the initial FDD, the higher the decrease in GFR. This
implies that diminished TGF activity in hyperfiltering diabetics
may be related to a decreased stimulus, that is, reduced NaCI
concentration or rate at the macula densa. Microperfusion
experiments in nondiabetic rats have confirmed that benzola-
mide or acetazolamide increased renal vascular resistance and
decreased GFR through increased Na distal delivery and TGF
response [35, 36]. It is noteworthy that in diabetic animals with
glucosuria and presumed increase in distal Na delivery due to
osmotic load, reduced GFR or SNGFR and elevated renal
arteriolar resistance have usually been found [4, 37].
In IDDM patients, different patterns were noted in the renal
response to acute administration of either ACE inhibitor or
calcium channel blocker. Indeed, GFR decreased after capto-
pril but not after nicardipine administration, whereas renal
vascular resistance was reduced to a comparable degree and
RPF increased slightly but not significantly in both conditions.
This renal hemodynamic response was similar to that found in
normal subjects after acute captopril or nicardipine administra-
tion [38, 39]. In diabetic rats, elevated GFR was found to be
reduced after chronic ACE! treatment but unchanged after
calcium channel blocker [40]. In our study, as in others [41,42],
FF decreased markedly after captopril, supporting a preferen-
tial reduction in efferent arteriolar resistance. Decrease in zP
has also been reported [6] after ACEI administration in exper-
imental diabetes. Since the ultrafiltration coefficient (Kf) exhib-
its an upward trend after ACE inhibition [43], associated
reduction in both GFR and FF may represent indirect evidence
of reduction in glomerular transcapillary pressure gradient (P).
Our results also indicate that renal angiotensin II plays a role in
the control of GFR in IDDM despite evidence of a depression in
the renin-angiotensin system and a reduction in the glomerular
angiotensin II receptor density [44].
In contrast, nicardipine administration reduced renal vascu-
lar resistance without change in GFR, probably because the
pre/postglomerular resistance ratio was unchanged or slightly
decreased. Although the vasorelaxing action of calcium antag-
onists is assumed to preferentially affect the preglomerular
resistance vessels [45], the slight decrease in FF after calcium
channel blockade suggests an additional effect of CCB on
efferent resistance as indicated by a study where verapamil
decreased angiotensin-induced efferent vasoconstriction [461.
In our study, further decrease in RVR after calcium channel
blockade implies a less than maximal vasorelaxation of RA in
IDDM.
In the current study, the reduction in GFR after acute
captopril administration was accompanied by proportional
changes in absolute proximal reabsorption rates of sodium.
Thus glomerulo-tubular balance was well preserved and abso-
lute distal delivery of sodium was unaltered. As distal reabsorp-
tion was unchanged, there was no difference in urinary excre-
tion of sodium before and after captopril. By contrast, ACE!
are known to acutely induce natriuresis in animals and humans
[47—50], including normotensives. In normotensive non-diabetic
subjects studied using the same protocol [38] we found that
ACE! acutely induced a marked increase in sodium urinary
excretion (+ 19%) and in fractional sodium excretion (+37%)
essentially related to the reduction in fractional proximal reab-
sorption, suggesting that physiological angiotensin II concen-
trations may increase proximal tubular reabsorption either
directly by an affect on the proximal tubule [51] or indirectly by
changes in peritubular capillary dynamics [521. In the present
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Appendix. Abbreviations and formulas used to express
segmental tubular handling of sodium.
:Sodium clearance
Plasma sodium concentration
Lithium clearance
:Filtered load of sodium (= GFR X P x l0-)
:Fractional proximal sodium reabsorption rate (= 1 — CLI!
GFR)
:Absolute proximal sodium reabsorption rate (= (GFR — CLI)
Na >< 10
:Absolute distal fluid delivery (= C)
:Fractional distal delivery of sodium (= CL/GFR)
:Fractional distal sodium reabsorption rate ( 1 — CNa/CLI)
:Absolute distal sodium reabsorption rate (= (CLI — CNa) x
x 10-i)
:Fractional excretion of sodium (= CNa/GFR)
Urinary excretion of sodium
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